Silvia Sookoian, MD, PhD, FAASLD

Biography

She has a position as a physician scientist devoted to translating scientific knowledge in Hepatology into the patients care. She received her MD and Ph.D. at the University of Buenos Aires, School of Medicine. She has a master in molecular medicine. Her current clinical and translational research is focused on genetic, epigenetic, and molecular mechanisms implicated in MASLD pathogenesis and disease progression. Dr. Sookoian has published extensively in the field of Liver Diseases, including MASLD/MASH and hepatitis C. She has been in clinical practice since 1987 (Clinical Training Board certificated in Internal Medicine; Fellowship in Hepatology). She received training in Hepatology (Karolinska Institute, Huddinge University Hospital. Sweden. 1997: Hepatology Centers of Excellence Program; pathology (Armed Forces Institute of Pathology. Washington DC. 2000); genetics of complex diseases (Cold Spring Harbor Laboratories. NY, USA, and Wellcome Trust Advanced Courses 2006). She is now a Senior Research Scientist. CONICET (National Scientific and Technical Research Council). Head of the Clinical & Molecular Hepatology. CENITRES (Translational Health Research Center). Dean of the Faculty of Health Science. Maimonides University. Buenos Aires. Argentina. Full professor of Medicine. Maimonides University. Buenos Aires. Argentina. Relevant international professional service: Member of the Program Evaluation Committee American Association for the Study of Liver Disease (AASLD) 2010-2013. Member of the Steering Committee Steatosis and Steatohepatitis Special Interest Group of AASLD and Co-Chair of its global outreach subcommittee (2018-2020). Member of the Latin American Regional Advisory Council of AASLD). Scientific Committee Italian Liver Foundation. She is currently editorial board member GUT (2015-current) and International Editorial Board Journal of Alimentary Pharmacology and Therapeutics (2020-current). Journal of Hepatology (2025-current). Associate/Academic Editor of Hepatobiliary Surgery and Nutrition (HBSN) (2021-current); Clinical and Molecular Hepatology Country (2020-current); and Journal of Lipid Research (2024-current). Liver International (2025-current).